gefitinib has been researched along with acetamide in 3 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (acetamide) | Trials (acetamide) | Recent Studies (post-2010) (acetamide) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 388 | 1 | 167 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Alfieri, R; Bonelli, M; Bozza, N; Callegari, D; Castelli, R; Cavazzoni, A; Digiacomo, G; Ferlenghi, F; Fumarola, C; Lodola, A; Mor, M; Petronini, PG; Rivara, S; Silva, C; Vacondio, F | 1 |
An, T; Deng, X; Hu, C; Jin, Z; Ma, Q; Meng, Q; Tan, X; Wang, C | 1 |
3 other study(ies) available for gefitinib and acetamide
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR.
Topics: A549 Cells; Acetamides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cysteine; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Phosphorylation; Thioacetamide | 2019 |
Synthesis, Characterization, and Biological Activity of a Novel Series of Benzo[4,5]imidazo[2,1-
Topics: Acetamides; Antineoplastic Agents; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Molecular Docking Simulation; Neoplasms; Thiazoles | 2019 |